BAP1 and neoplasm: In the univariate analysis, tumor stage (hazard ratio (HR) = 4.69, p-value = 1.48 × 10−9), age (HR = 1.04, p-value = 2.25 × 10−5), KIRC risk group based on the seven MDEGs (HR = 5.15, p-value = 1.17 × 10−7), and mutation status of BAP1 (HR = 2.05, p-value = 0.01) were significantly associated with overall survival (OS) in KIRC patients.